X4 Pharmaceuticals, Inc

Form D Filings

Location
Boston, MA
Industry Group
Biotechnology
Related People
Adam Craig, John Volpone, Christophe Arbet-Engels, Mark Baldry, Mary DiBiase, David Kirske, Gary J. Bridger, Francoise De Craecker, Murray W. Stewart, Michael S. Wyzga, Paula Ragan, Adam Mostafa, Arthur Taveras, Murray Stewart, William Aliski, Alison Lawton, Gary Bridger, David McGirr, Michael Wyzga, Adam S. Mostafa, Diego Cadavid, Derek Meisner, William E. Aliski, Rene Russo, Michael Gray, Tillman U. Gerngross, Eszter Nagy, William Clark, Carl Gordon, Terrance McGuire, Claudio Nessi, Michael Ross, Amy Schulman, David Mantus, Chris Stevens, Dan Burgess, Jan Adams, Tillman Gerngross, Daniel Burgess, Tillman U Gerngross, Errik B Anderson, Errik B. Anderson, Robert L. Birnbaum
Entity Type
Corporation
CIK
0001501697
Previous Names
X4 Pharmaceuticals, Inc, Arsanis, Inc.
All SEC Filings
View on sec.gov
Date Filed Security Types Amount Sold Diff Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
8/25/2025 Equity, Option to Acquire, Security to be Acquired $84,999,985 $84,999,985 $84,999,985 $0 8/13/2025 8/25/2025 D 000147083125000145
6/1/2023 Equity, Option to Acquire, Security to be Acquired $65,015,462 $65,015,462 $65,023,725 $8,263 5/18/2023 6/1/2023 D 000123191923000037
7/19/2022 Equity, Option to Acquire, Security to be Acquired $55,749,999 $55,749,999 $111,526,550 $55,776,551 7/6/2022 7/19/2022 D 000123191922000047
12/4/2017 Equity $20,000,000 $20,000,000 $20,000,000 $0 11/20/2017 12/4/2017 D 000150169717000004
5/8/2017 Equity $45,539,314 $45,539,314 $50,539,341 $5,000,027 4/24/2017 5/5/2017 D 000150169717000002
4/27/2016 Equity, Debt $15,007,220 $15,007,220 $15,007,220 $0 4/12/2016 4/27/2016 D 000150169716000005
12/30/2015 Debt $4,000,000 $4,000,000 $4,000,000 $0 12/16/2015 12/30/2015 D 000150169715000004
6/5/2015 Equity $7,000,001 $20,000,000 $20,000,000 $0 7/30/2013 6/5/2015 D/A 000150169715000003
8/11/2014 Equity $0 $12,999,999 $20,000,000 $7,000,001 7/30/2013 8/8/2014 D/A 000150169714000001
8/13/2013 Equity $12,999,999 $12,999,999 $20,000,000 $7,000,001 7/30/2013 8/12/2013 D 000150169713000002
2/7/2011 Equity $9,600,002 $9,600,002 $9,600,002 $0 1/31/2011 2/7/2011 D 000150169711000001
9/24/2010 Equity $400,002 $400,002 $400,002 $0 9/15/2010 9/23/2010 D 000150169710000001